Equities

Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)987.15
  • Today's Change7.15 / 0.73%
  • Shares traded45.82k
  • 1 Year change-39.62%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments457412638
Total Receivables, Net881968694
Total Inventory1,5281,6251,700
Prepaid expenses764324
Other current assets, total37751,303
Total current assets2,9793,1234,359
Property, plant & equipment, net5,0314,2652,108
Goodwill, net------
Intangibles, net3.514.763.17
Long term investments------
Note receivable - long term------
Other long term assets513221
Total assets8,1877,5896,583
LIABILITIES
Accounts payable450322445
Accrued expenses765165
Notes payable/short-term debt1001,562925
Current portion long-term debt/capital leases3698144
Other current liabilities, total134354136
Total current liabilities7972,3871,714
Total long term debt6.3942131
Total debt1431,7031,199
Deferred income tax----0
Minority interest------
Other liabilities, total13116.68
Total liabilities8162,4411,852
SHAREHOLDERS EQUITY
Common stock234222222
Additional paid-in capital4,0442,0902,090
Retained earnings (accumulated deficit)3,0772,8222,413
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total16146.19
Total equity7,3715,1484,731
Total liabilities & shareholders' equity8,1877,5896,583
Total common shares outstanding232222
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.